Phase I/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysm

To determine the safety, tolerability, pharmacokinetics, and immunomodulatory effects of a 6-week course of atorvastatin in patients with acute Kawasaki disease with coronary artery (CA) aneurysm (CAA).

Source: The Journal of Pediatrics - September 23, 2019 Category: Pediatrics Authors: Adriana H. Tremoulet, Sonia Jain, Pei-Ni Jone, Brookie M. Best, Elizabeth H. Duxbury, Alessandra Franco, Beth Printz, Samuel R. Dominguez, Heather Heizer, Marsha S. Anderson, Mary P. Glod é, Feng He, Robert L. Padilla, Chisato Shimizu, Emelia Bainto, Joa Tags: Original Articles Source Type: research